TABLE OF CONTENTS
Trypanosoma cruzi (Chagas Disease Parasite): Morphology, Transmission, Clinical Signs, Diagnosis & Treatment
Trypanosoma cruzi is a hemoflagellate protozoan parasite of the subgenus Schizotrypanum and the causative agent of Chagas disease (American trypanosomiasis). It is an important zoonotic parasite endemic to Latin America and is primarily transmitted by blood-sucking triatomine (reduviid) bugs. In addition to vector-borne transmission, the parasite can spread through blood transfusion, organ transplantation, congenital transmission, and, less commonly, contaminated food.
T. cruzi has a complex life cycle involving both insect vectors and mammalian hosts. Following infection, it multiplies as amastigotes within host cells and later circulates as trypomastigotes in the bloodstream, causing acute or chronic disease. Chronic infection can lead to severe cardiac and gastrointestinal complications, making T. cruzi a significant public health concern. This article covers the taxonomy, morphology, transmission, pathogenesis, clinical signs, diagnosis, and treatment of Trypanosoma cruzi.
Parasite Overview
- Host: Humans, chiefly infants and young children
- Vector: Reduviid bugs (triatomine bugs), especially Rhodnius prolixus
- Reservoir Hosts: Armadillos and opossums
- Disease: Chagas disease, chagoma, and American trypanosomiasis
Taxonomical Classification
- Kingdom: Protista
- Phylum: Euglenozoa
- Class: Kinetoplastea
- Order: Trypanosomatida
- Family: Trypanosomatidae
- Genus: Trypanosoma
- Subgenus: Schizotrypanum
- Species: Trypanosoma cruzi
- Common Name: Chagas disease parasite, American trypanosome
Morphology
T. cruzi is monomorphic and crescent-shaped with a pointed posterior end. The kinetoplast is large and subterminal.
It has a moderately well-developed undulating membrane and a free flagellum. The organism divides in the amastigote stage within the cardiac muscle.
Transmission and Development
T. cruzi is transmitted by blood-sucking reduviid bugs, which usually defecate shortly after feeding. In the vector, development of the organism occurs in the posterior station. When an infected bug feeds on a human, metacyclic trypanosomes are passed in the feces.
Because of irritation at the feeding site, the individual may scratch the area, allowing the metacyclic trypanosomes to be rubbed into the wound created by the bug. The parasite can also be transmitted through blood transfusion and transplacental transmission.
Following infection, the organisms enter histiocytes and proliferate as amastigotes at the local site. The amastigotes then spread from the primary site to the regional lymph nodes and are subsequently distributed throughout the body via the lymphatic system.
The liver, spleen, bone marrow, cardiac muscle, and cerebral cortex are affected. In these organs, the organisms multiply as amastigotes. Eventually, the amastigotes transform into trypomastigotes, which are released into the bloodstream when infected host cells rupture.
Pathogenesis and Clinical Signs
Initially, the proliferation of amastigotes at the site of infection may cause a local inflammatory response, which later becomes encapsulated by fibrous tissue. This may obstruct the local lymphatics, resulting in edema of the affected area. This lesion is known as a primary lesion or chagoma.
The pathological changes consist of extensive destruction of reticuloendothelial cells and muscle cells.
The disease in humans may occur in either an acute or chronic form. The acute form usually affects infants and young children, whereas the chronic form is more common in adults.
Clinical manifestations include megacolon and megaesophagus resulting from ganglionic damage caused by toxins produced by the parasites. In acute cases, death may occur 2–4 weeks after the onset of clinical signs. In dogs, debility, anemia, and splenomegaly may occur. In cats, convulsions and posterior paralysis may be observed.
Diagnosis
Diagnosis is made by examination of blood smears for the demonstration of the trypomastigote stage.
The following serological tests are also used:
- Complement fixation (CF)
- Indirect fluorescent antibody test (IFAT)
- Indirect hemagglutination test (IHA)
- Direct agglutination test (DAT)
Xenodiagnosis is commonly used to confirm Chagas disease in humans. In this test, laboratory-reared triatomine bugs are allowed to feed on the patient’s blood through a membrane. If the blood sample is positive, metacyclic trypanosomes can be demonstrated in the feces of the bugs 7–10 days after feeding.
PCR may also be used for early detection and confirmation of T. cruzi infection, particularly during the acute phase.
Treatment
The treatment of Trypanosoma cruzi infection primarily relies on antitrypanosomal drugs, with benznidazole and nifurtimox being the drugs of choice. These medications are most effective during the acute phase of infection and in cases of recent congenital infection.
Supportive and symptomatic therapy is essential for managing complications associated with chronic Chagas disease, including cardiac arrhythmias, heart failure, and gastrointestinal disorders such as megaesophagus and megacolon.
